These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 32144167

  • 1. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
    Fabris C, Nass RM, Pinnata J, Carr KA, Koravi CLK, Barnett CL, Oliveri MC, Anderson SM, Chernavvsky DR, Breton MD.
    Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
    [Abstract] [Full Text] [Related]

  • 2. Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia Contribution.
    Fabris C, Ozaslan B, Breton MD.
    Sensors (Basel); 2019 Dec 06; 19(24):. PubMed ID: 31817678
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
    Lepore G, Dodesini AR, Nosari I, Scaranna C, Corsi A, Trevisan R.
    Nutr Metab Cardiovasc Dis; 2012 Aug 06; 22(8):e15-6. PubMed ID: 22673770
    [No Abstract] [Full Text] [Related]

  • 5. Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children - randomized controlled trial.
    Ramotowska A, Szypowska A.
    Diabetes Metab Res Rev; 2014 Feb 06; 30(2):146-53. PubMed ID: 24115314
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
    Jones SM, Quarry JL, Caldwell-McMillan M, Mauger DT, Gabbay RA.
    Diabetes Technol Ther; 2005 Apr 06; 7(2):233-40. PubMed ID: 15857224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy.
    Gross TM, Kayne D, King A, Rother C, Juth S.
    Diabetes Technol Ther; 2003 Apr 06; 5(3):365-9. PubMed ID: 12828818
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comprehensive Analysis of the Real Lifestyles of T1D Patients for the Purpose of Designing a Personalized Counselor for Prandial Insulin Dosing.
    Stechova K, Hlubik J, Pithova P, Cikl P, Lhotska L.
    Nutrients; 2019 May 23; 11(5):. PubMed ID: 31126048
    [Abstract] [Full Text] [Related]

  • 12. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D, Biagioni M, Allen JM, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Haidar A, Calhoun P, Kollman C, Jackson NC, Umpleby AM, Acerini CL, Dunger DB, Hovorka R.
    Diabetes Obes Metab; 2015 Dec 23; 17(12):1173-9. PubMed ID: 26257323
    [Abstract] [Full Text] [Related]

  • 13. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.
    Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.
    J Diabetes Sci Technol; 2009 Sep 01; 3(5):1031-8. PubMed ID: 20144416
    [Abstract] [Full Text] [Related]

  • 14. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
    Rossetti P, Quirós C, Moscardó V, Comas A, Giménez M, Ampudia-Blasco FJ, León F, Montaser E, Conget I, Bondia J, Vehí J.
    Diabetes Technol Ther; 2017 Jun 01; 19(6):355-362. PubMed ID: 28459603
    [Abstract] [Full Text] [Related]

  • 15. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
    Wood MA, Shulman DI, Forlenza GP, Bode BW, Pinhas-Hamiel O, Buckingham BA, Kaiserman KB, Liljenquist DR, Bailey TS, Shin J, Huang S, Chen X, Cordero TL, Lee SW, Kaufman FR.
    Diabetes Technol Ther; 2018 Nov 01; 20(11):731-737. PubMed ID: 30299976
    [Abstract] [Full Text] [Related]

  • 16. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.
    Franc S, Daoudi A, Pochat A, Petit MH, Randazzo C, Petit C, Duclos M, Penfornis A, Pussard E, Not D, Heyman E, Koukoui F, Simon C, Charpentier G.
    Diabetes Obes Metab; 2015 Dec 01; 17(12):1150-7. PubMed ID: 26264812
    [Abstract] [Full Text] [Related]

  • 17. Simulation-Based Evaluation of Treatment Adjustment to Exercise in Type 1 Diabetes.
    Deichmann J, Bachmann S, Burckhardt MA, Szinnai G, Kaltenbach HM.
    Front Endocrinol (Lausanne); 2021 Dec 01; 12():723812. PubMed ID: 34489869
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
    Castle JR, El Youssef J, Wilson LM, Reddy R, Resalat N, Branigan D, Ramsey K, Leitschuh J, Rajhbeharrysingh U, Senf B, Sugerman SM, Gabo V, Jacobs PG.
    Diabetes Care; 2018 Jul 01; 41(7):1471-1477. PubMed ID: 29752345
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.